Atlas Trials

Isoniazid Dose Adjustment According to NAT2 Genotype (IDANAT2)

Clinical trial NCT00571753 · TERMINATED

Trial details

NCT number
NCT00571753
Sponsor
University of Cologne
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Pulmonary Tuberculosis
Start date
2008-06-01
Primary completion
2011-12-01
Enrollment
900

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.